Cellebrite DI Ltd.

NASDAQ: CLBTW · Real-Time Price · USD
5.25
-0.69 (-11.62%)
At close: Sep 16, 2024, 10:00 PM

Cellebrite DI Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-283.01M -81.1M 120.81M 71.4M
Depreciation & Amortization
10.61M 10.01M 9.19M 7.09M
Stock-Based Compensation
30.57M 19M 13.71M 6.48M
Other Working Capital
26.55M 31.58M 19.22M 20.19M
Other Non-Cash Items
335.96M 110.5M -117.92M -67.86M
Deferred Income Tax
-4.01M 5.13M -2.39M -1.64M
Change in Working Capital
42.05M 38.52M -2.82M 20.59M
Operating Cash Flow
132.17M 102.06M 20.58M 36.05M
Capital Expenditures
-10.61M -7.92M -9.09M -8.11M
Cash Acquisitions
-2.75M n/a 106.61M -20M
Purchase of Investments
-127.79M -55.32M -165.36M -21M
Sales Maturities Of Investments
59.97M 56.34M 83.22M 94.34M
Other Investing Acitivies
-68.3M -15.64M -106.61M 70.34M
Investing Cash Flow
-149.47M -22.54M -91.23M 45.23M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-11K n/a n/a n/a
Dividend Paid
n/a n/a n/a -100M
Other Financial Acitivies
20.65M 21.77M 13.97M 31.6M
Financial Cash Flow
20.65M 21.77M 13.97M -68.4M
Net Cash Flow
2.14M 101.87M -58.33M 12.13M
Free Cash Flow
121.56M 94.14M 11.49M 27.94M